Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Lucentis (ranibizumab) - Important Safety Information from Novartis Europharm Ltd as approved by the HPRA
Notice type:
3rd Party Publications
Date:
22/11/2019
Problem Or Issue:
Important Safety Information from Novartis Europharm Ltd regarding plunger on syringe too stiff - Lucentis (ranibizumab) 10 mg/mL pre-filled syringe
Important Safety Information - Lucentis (ranibizumab)
« Back
Date Printed: 24/04/2024